Adicet bio to participate in upcoming investor conferences

Menlo park, calif., feb. 11, 2021 (globe newswire) -- adicet bio, inc. (nasdaq: acet), a biotechnology company discovering and developing allogeneic gamma delta t cell therapies for cancer and other diseases, today announced that the company management will participate in three upcoming virtual investor conferences.
ACET Ratings Summary
ACET Quant Ranking